Neurologists’ Knowledge, Practice, and Attitudes towards Pharmacovigilance and Adverse Drug Reactions Reporting Process in Epileptic Patients—Comparative Analysis from Poland and Egypt

Dorota Kopciuch, Nashwa Nabil Kamal, Nashaat Nabil Kamal, Nermin Aly Hamdy, Anna Paczkowska, Tomasz Zaprutko, Piotr Ratajczak, Jędrzej Fliciński, Krzysztof Kus and Elżbieta Nowakowska
Additional contact information
Dorota Kopciuch: Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland
Nashwa Nabil Kamal: Department of Public Health and Preventive Medicine, Faculty of Medicine, Minia University, Minia 61-511, Egypt
Nashaat Nabil Kamal: Department of Public Health and Preventive Medicine, Faculty of Medicine, Minia University, Minia 61-511, Egypt
Nermin Aly Hamdy: Department of Neurology and Psychiatry, Minia University, Minya 61-511, Egypt
Anna Paczkowska: Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland
Tomasz Zaprutko: Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland
Piotr Ratajczak: Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland
Jędrzej Fliciński: Department of Developmental Neurology, Poznan University of Medical Sciences, 60-355 Poznan, Poland
Krzysztof Kus: Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland
Elżbieta Nowakowska: Department of Pharmacology and Toxicology Institute of Health Sciences, Collegium Medicum, University of Zielona Gora, 65-417 Zielona Góra, Poland

IJERPH, 2022, vol. 19, issue 7, 1-16

Abstract: Objectives: To compare neurologists’ knowledge, practice, and barriers of pharmacovigilance (PV) process among patients with epilepsy in Poland and Egypt. Methods: It was an international study that used an online questionnaire e-mailed to neurologists registered to practice in Poland and Egypt. Results: Most of the neurologists were familiar with the definition of PV and adverse drug reactions (ADRs), but relatively few neurologists knew where to report ADRs, especially the Egyptian neurologists. Only 31.11% of the neurologists from Egypt and 39.90% neurologists from Poland declared that they had reported ADRs at least once during their professional practice, and few of them declared the regular reporting of such incidents. The main reason for the neurologists not reporting ADRs was the lack of time and a conviction that reporting ADRs would be an additional burden that would generate extra work. Conclusion: The standards of pharmacovigilance process, safety control, and quality are not the same throughout the world. System-regulated PV stabilization in a country translates into the practice of maintaining PV. Monitoring the safety of pharmacotherapy and knowledge of risks associated with ADRs should be included in the academic curricula of physician courses.

Keywords: pharmacovigilance; epilepsy; adverse drug reactions; drug safety; neurologists’ knowledge; Poland; Egypt (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/7/4169/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/7/4169/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:7:p:4169-:d:784517

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().